Data / Form D filings / ProstaGene, LLC
ProstaGene, LLC: Form D filings
ProstaGene, LLC, a pharmaceuticals company in Wynnewood, PA, filed 3 Form D notices with the SEC between 2015 and 2016. The latest, on April 20, 2016, reports $400,000 sold of a $1.4 million offering to 4 investors.
Find out what ProstaGene, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 East Lancaster Avenue, #133, Wynnewood, PA, 19096
- Phone
- (267) 402-0545
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1635915
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 20, 2016 | New notice | $1,400,000 | $400,000 | $1,000,000 | 4 | Apr 8, 2016 | sec.gov |
| May 19, 2015 | Amendment | $1,000,000 | $825,000 | $175,000 | 6 | Feb 23, 2015 | sec.gov |
| Mar 10, 2015 | New notice | $700,000 | $400,000 | $300,000 | 2 | Feb 23, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Pestell | Executive Officer, Director | |
| Dan Matthias | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Apr 18, 2016 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ProstaGene, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.